FDA Orphan Drug DesignationThis designation provides tax credits and market exclusivity, enhancing DiagnaMed's ability to accelerate development programs and potentially improving its market position in rare disease therapeutics.

Hydrogen Technology CommercializationProgress in hydrogen technology can open new revenue streams and align with global low-carbon energy trends, strengthening DiagnaMed's market presence and operational capabilities.

Private Placement FundingThe funding supports R&D and commercialization efforts, potentially enhancing DiagnaMed's product offerings and market competitiveness in cleantech and life sciences sectors.

Bears Say

Zero RevenueThe inability to generate revenue indicates significant challenges in market penetration and product monetization, threatening long-term financial sustainability and growth potential.

Negative EquityNegative equity reflects financial distress and declining stability, limiting DiagnaMed's ability to invest in growth opportunities and potentially impacting its creditworthiness.

Negative Cash FlowInefficient cash management and lack of positive cash flow conversion from operations stress financial instability, hindering DiagnaMed's ability to fund operations and strategic initiatives.

DiagnaMed Holdings Corp. News

DiagnaMed Expands Natural Hydrogen Portfolio with Strategic Acquisition in Nova Scotia

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) just unveiled an update. DiagnaMed Holdings Corp. has entered into an acquisition...

3M ago

DiagnaMed Expands Hydrogen Zone in Ontario’s Témiscamingue Graben

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) has issued an announcement. DiagnaMed Holdings Corp., in collaboration with Québec Innovative...

4M ago

DiagnaMed and QIMC Unveil Major Natural Hydrogen Discovery in Ontario

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) just unveiled an update. DiagnaMed Holdings Corp. and Québec Innovative Materials Corp....

4M ago

DiagnaMed Enhances Leadership Amid Key Exploration Milestone

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) has provided an announcement. DiagnaMed Holdings Corp. has strengthened its leadership team...

5M ago

DiagnaMed Advances Hydrogen Initiatives with Key Collaborations

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) has issued an update. DiagnaMed Holdings Corp. has announced significant progress in...

7M ago

DiagnaMed Aligns Leadership with Shareholders Through Equity Incentives

The latest update is out from DiagnaMed Holdings Corp. ( ($TSE:DMED) ). DiagnaMed Holdings Corp. has issued 3,000,000...

7M ago

DiagnaMed Announces CFO Transition Amidst Strategic Growth

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) has shared an update. DiagnaMed Holdings Corp. announced a transition in its...

7M ago

DiagnaMed Launches Ontario Hydrogen Exploration and Strengthens Board

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) has issued an update. DiagnaMed Holdings Corp. has announced a new hydrogen...

8M ago

DiagnaMed Advances Hydrogen & Helium Exploration in Ontario

DiagnaMed Holdings Corp. ( ($TSE:DMED) ) just unveiled an announcement. DiagnaMed Holdings Corp. has advanced its Ontario Natural...

8M ago

DiagnaMed Appoints New CEO to Drive Hydrogen Sector Growth

An announcement from DiagnaMed Holdings Corp. ( ($TSE:DMED) ) is now available. DiagnaMed Holdings Corp. has appointed John...

9M ago

DMED FAQ

What was DiagnaMed Holdings Corp.’s price range in the past 12 months?

DiagnaMed Holdings Corp. lowest stock price was C$0.02 and its highest was C$0.14 in the past 12 months.

What is DiagnaMed Holdings Corp.’s market cap?

DiagnaMed Holdings Corp.’s market cap is C$8.00M.

When is DiagnaMed Holdings Corp.’s upcoming earnings report date?

DiagnaMed Holdings Corp.’s upcoming earnings report date is Jun 03, 2026 which is in 99 days.

How were DiagnaMed Holdings Corp.’s earnings last quarter?

Currently, no data Available

Is DiagnaMed Holdings Corp. overvalued?

According to Wall Street analysts DiagnaMed Holdings Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does DiagnaMed Holdings Corp. pay dividends?

DiagnaMed Holdings Corp. does not currently pay dividends.

What is DiagnaMed Holdings Corp.’s EPS estimate?

DiagnaMed Holdings Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does DiagnaMed Holdings Corp. have?

DiagnaMed Holdings Corp. has 114,267,300 shares outstanding.

What happened to DiagnaMed Holdings Corp.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of DiagnaMed Holdings Corp.?

Currently, no hedge funds are holding shares in TSE:DMED

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

DiagnaMed Holdings Corp.

Diagnamed Holdings Corp. engages in developing a platform of software-based prescription digital therapeutic products for detecting brain age and tremors for neurological disorders. The company is headquartered in Vancouver, Canada.